These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22261819)

  • 1. Nowhere patients.
    Tomba E
    Psychother Psychosom; 2012; 81(2):69-72. PubMed ID: 22261819
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.
    Sokolski KN; Gripeos D
    Ann Pharmacother; 2008 Sep; 42(9):1348-9. PubMed ID: 18682539
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
    Fava M; Mischoulon D; Iosifescu D; Witte J; Pencina M; Flynn M; Harper L; Levy M; Rickels K; Pollack M
    Psychother Psychosom; 2012; 81(2):87-97. PubMed ID: 22286203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole adjunctive to antidepressant therapy.
    Marcus RM; Sanchez R; Frost M; McQuade RD
    Am J Psychiatry; 2011 Feb; 168(2):211; author reply 211. PubMed ID: 21297051
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
    Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
    J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole as an adjunctive treatment for refractory major depression.
    Hellerstein DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1347-8. PubMed ID: 15588762
    [No Abstract]   [Full Text] [Related]  

  • 9. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole.
    Arnold KK; Yager J
    J Clin Psychiatry; 2007 Oct; 68(10):1620-1. PubMed ID: 17960985
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.
    Han DH; Kim SM; Choi JE; Min KJ; Renshaw PF
    J Psychopharmacol; 2013 Mar; 27(3):282-91. PubMed ID: 23325372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
    Nagoshi Y; Tominaga T; Fukui K
    J Clin Psychopharmacol; 2014 Jun; 34(3):397-8. PubMed ID: 24525655
    [No Abstract]   [Full Text] [Related]  

  • 13. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
    Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
    J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole augmentation of antidepressants for postpartum depression: a preliminary report.
    Sharma V; Sommerdyk C; Xie B
    Arch Womens Ment Health; 2015 Feb; 18(1):131-4. PubMed ID: 25223952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
    Goforth HW; Carroll BT
    J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
    [No Abstract]   [Full Text] [Related]  

  • 16. Does aripiprazole protect from serotonin syndrome?
    Rittmannsberger H; Werl R
    Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
    Simon JS; Nemeroff CB
    J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole augmentation for a patient with partial remission of panic disorder.
    Harada T; Yamada K; Sakamoto K; Ishigooka J
    J Clin Psychopharmacol; 2009 Jun; 29(3):301-2. PubMed ID: 19440089
    [No Abstract]   [Full Text] [Related]  

  • 19. An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
    Matthews JD; Siefert C; Dording C; Denninger JW; Park L; van Nieuwenhuizen AO; Sklarsky K; Hilliker S; Homberger C; Rooney K; Fava M
    J Clin Psychopharmacol; 2009 Feb; 29(1):73-6. PubMed ID: 19142112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.
    Rutherford B; Sneed J; Miyazaki M; Eisenstadt R; Devanand D; Sackeim H; Roose S
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):986-91. PubMed ID: 17340654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.